93 research outputs found

    Comportement et étude des graves-émulsion: Coopération public-privé. Méthodologie de préparation, d'instrumentation et de suivi de chantiers expérimentaux d'enrobés à froid à l'émulsion de bitume

    No full text
    Les mĂ©langes Ă  l'Ă©mulsion de bitume sont des techniques Ă  fort potentiel environnemental. Cependant, leur formulation, fabrication et dimensionnement relĂšvent encore de dĂ©marches empiriques issues, bien souvent, de compĂ©tences locales. Pour caractĂ©riser les performances spĂ©cifiques de ces matĂ©riaux et aboutir Ă  terme Ă  des mĂ©thodologies d'optimisation, de formulation et de dimensionnement, il est nĂ©cessaire d'Ă©valuer leur comportement in situ. Pour rĂ©pondre Ă  ces objectifs, il convent donc de suivre l'Ă©volution des caractĂ©ristiques mĂ©caniques et physiques du matĂ©riau tout au long des Ă©tapes de fabrication, de mise en oeuvre et en conditions de service au moyen d'une instrumentation adaptĂ©e et implantĂ©e dans la chaussĂ©e. Ce type d'instrumentation n'ayant jamais Ă©tĂ© utilisĂ© en France sur grave-Ă©mulsion, une mĂ©thodologie appropriĂ©e doit ĂȘtre dĂ©finie. C'est l'objet du prĂ©sent article qui met en avant les spĂ©cificitĂ©s d'un chantier expĂ©rimental instrumentĂ© de grave-Ă©mulsion. Il dĂ©crit et justifie la mĂ©thodologie suivie, les capteurs employĂ©s, leur implantation, de mĂȘme que les moyens de reconnaissance des pathologies des structures de chaussĂ©es utilisĂ©s. Il prĂ©sente les indicateurs retenus pour Ă©valuer le comportement des matĂ©riaux et de la structure

    The Maraichine Cattle Breed Supports Breeders and Researchers in the Atlantic Coastal Marshlands

    Get PDF
    The Maraichine breed of cattle originates from the Loire region of France and has been under a conservation programme since 1986. This programme links the conservation of the breed with the conservation of its traditional environment of wet grasslands. In this case report, we describe the different steps of this programme, each of which had its own successes and challenges. We also describe how, throughout this process, researchers have been involved in the generation and dissemination of information covering areas such as stakeholder perspectives, animal performance, and socio-economics. Under the conservation programme, the Maraichine population has expanded in both size and scale. Simultaneously, stakeholder perspectives have also developed, continually shifting the balance between the productivity, conservation, and maintenance of heritage traits. The conservation programme also provided the opportunity to utilise the breedĂąïżœïżœs desirable traits, such as easy calving and disease resistance. Whilst the carcasses are not necessarily as valuable as those of other breeds, farmers have implemented novel economic practices to capitalise on market opportunities. Today, Maraichine cattle and Maraichine breeders offer researchers the opportunity to deepen and enrich our knowledge on sustainable ruminant livestock farming systems

    Comportement et étude des graves-émulsion Coopération public-privé. Chantier expérimental de la RD 44: Suivi du comportement dans le temps

    No full text
    La section expĂ©rimentale de la RD 44 prĂšs de Rennes, rĂ©alisĂ©e en collaboration entre l'IFSTTAR, le RST, l'URSIF et le conseil gĂ©nĂ©ral d'Ille-et-Vilaine vise Ă  suivre l'Ă©volution des caractĂ©ristiques mĂ©caniques et physiques du matĂ©riau tout au long des Ă©tapes de fabrication, de mise en oeÂœuvre et de service, au moyen d'une instrumentation adaptĂ©e et implantĂ©e dans la chaussĂ©e. Cet article est le second de la sĂ©rie consacrĂ©e Ă  la section. Il prĂ©sente les investigations effectuĂ©es en laboratoire sur le matĂ©riau prĂ©levĂ© sur chantier ainsi que le suivi temporel du comportement in situ de la grave-Ă©mulsion et de la structure mise en place grĂące Ă  des auscultations internes et externes

    Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

    Get PDF
    Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≄ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe

    A História da Alimentação: balizas historiogråficas

    Full text link
    Os M. pretenderam traçar um quadro da HistĂłria da Alimentação, nĂŁo como um novo ramo epistemolĂłgico da disciplina, mas como um campo em desenvolvimento de prĂĄticas e atividades especializadas, incluindo pesquisa, formação, publicaçÔes, associaçÔes, encontros acadĂȘmicos, etc. Um breve relato das condiçÔes em que tal campo se assentou faz-se preceder de um panorama dos estudos de alimentação e temas correia tos, em geral, segundo cinco abardagens Ia biolĂłgica, a econĂŽmica, a social, a cultural e a filosĂłfica!, assim como da identificação das contribuiçÔes mais relevantes da Antropologia, Arqueologia, Sociologia e Geografia. A fim de comentar a multiforme e volumosa bibliografia histĂłrica, foi ela organizada segundo critĂ©rios morfolĂłgicos. A seguir, alguns tĂłpicos importantes mereceram tratamento Ă  parte: a fome, o alimento e o domĂ­nio religioso, as descobertas europĂ©ias e a difusĂŁo mundial de alimentos, gosto e gastronomia. O artigo se encerra com um rĂĄpido balanço crĂ­tico da historiografia brasileira sobre o tema

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570
    • 

    corecore